IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHARYNA K ROSATI

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1588053607
CMS profile
11116662
Location
PITTSBURGH, PA

General Payments · PY2021–2024

$2,299.82

  • Reported across 118 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,000.84

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Medical PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,000.84 48

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $180.23 10
NOVARTIS PHARMACEUTICALS CORPORATION $163.39 12
SCPHARMACEUTICALS INC. $162.48 4
Acerta Pharma LLC $78.37 5
Novo Nordisk AS $61.83 1
Janssen Pharmaceuticals, Inc $59.01 4
BOSTON SCIENTIFIC CORPORATION $55.24 1
Kiniksa Pharmaceuticals International, plc $48.26 2
Merck Sharp & Dohme Corporation $35.42 2
Amgen Inc. $30.80 2
Kestra Medical Technology Services, Inc. $27.69 1
Medtronic, Inc. $27.04 1
CVRx Inc. $26.75 1
ABIOMED $23.67 1
Esperion Therapeutics, Inc. $20.66 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $9.64 2
PY2022 $213.86 7
PY2023 $1,075.48 61
PY2024 $1,000.84 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $23.67 07/22/2024 Food and Beverage Undisputed 01/23/2026 1142294293 CMS
Amgen Inc. $17.08 03/05/2024 Food and Beverage Undisputed 01/23/2026 1117368979 CMS
Amgen Inc. $13.72 07/17/2024 Food and Beverage Undisputed 01/23/2026 1117368981 CMS
AstraZeneca Pharmaceuticals LP $13.61 01/19/2024 Food and Beverage Undisputed 01/23/2026 1104467718 CMS
AstraZeneca Pharmaceuticals LP $16.57 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104642243 CMS
AstraZeneca Pharmaceuticals LP $16.71 03/26/2024 Food and Beverage Undisputed 01/23/2026 1104223875 CMS
AstraZeneca Pharmaceuticals LP $16.57 05/09/2024 Food and Beverage Undisputed 01/23/2026 1105642840 CMS
AstraZeneca Pharmaceuticals LP $14.91 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105817151 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.90 01/29/2024 Food and Beverage Undisputed 01/23/2026 1118068392 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.78 02/12/2024 Food and Beverage Undisputed 01/23/2026 1118068406 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.11 03/18/2024 Food and Beverage Undisputed 01/23/2026 1118068404 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.95 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118068402 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.29 05/29/2024 Food and Beverage Undisputed 01/23/2026 1118068398 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.36 07/24/2024 Food and Beverage Undisputed 01/23/2026 1118068396 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.96 08/28/2024 Food and Beverage Undisputed 01/23/2026 1118068394 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.48 09/23/2024 Food and Beverage Undisputed 01/23/2026 1118068400 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.20 11/14/2024 Food and Beverage Undisputed 01/23/2026 1118068388 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.20 12/09/2024 Food and Beverage Undisputed 01/23/2026 1118068390 CMS
Boston Scientific Corporation $55.24 01/12/2024 Food and Beverage Undisputed 01/23/2026 1092304103 CMS
CVRx, Inc. $26.75 01/01/2024 Food and Beverage Undisputed 01/23/2026 1138420957 CMS
Esperion Therapeutics, Inc. $20.66 12/11/2024 Food and Beverage Undisputed 01/23/2026 1129475336 CMS
Janssen Pharmaceuticals, Inc $13.82 03/25/2024 Food and Beverage Undisputed 01/23/2026 1078158847 CMS
Janssen Pharmaceuticals, Inc $13.62 04/11/2024 Food and Beverage Undisputed 01/23/2026 1078159141 CMS
Janssen Pharmaceuticals, Inc $18.36 07/06/2024 Food and Beverage Undisputed 01/23/2026 1078158981 CMS
Janssen Pharmaceuticals, Inc $13.21 08/07/2024 Food and Beverage Undisputed 01/23/2026 1078159129 CMS
Kestra Medical Technology Services, Inc. $27.69 06/09/2024 Food and Beverage Undisputed 01/23/2026 1152390525 CMS
Kiniksa Pharmaceuticals International, plc $20.31 03/19/2024 Food and Beverage Undisputed 01/23/2026 1154891685 CMS
Kiniksa Pharmaceuticals International, plc $27.95 08/09/2024 Food and Beverage Undisputed 01/23/2026 1154891753 CMS
Medtronic, Inc. $27.04 01/12/2024 Food and Beverage Undisputed 01/23/2026 1116965608 CMS
Merck Sharp & Dohme LLC $18.02 04/17/2024 Food and Beverage Undisputed 01/23/2026 1141656617 CMS
Merck Sharp & Dohme LLC $17.40 05/30/2024 Food and Beverage Undisputed 01/23/2026 1141924598 CMS
Novartis Pharmaceuticals Corporation $21.83 01/09/2024 Food and Beverage Undisputed 01/23/2026 1087179577 CMS
Novartis Pharmaceuticals Corporation $12.94 01/16/2024 Food and Beverage Undisputed 01/23/2026 1087179581 CMS
Novartis Pharmaceuticals Corporation $20.62 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087179579 CMS
Novartis Pharmaceuticals Corporation $9.93 04/24/2024 Food and Beverage Undisputed 01/23/2026 1087179583 CMS
Novartis Pharmaceuticals Corporation $12.35 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087179585 CMS
Novartis Pharmaceuticals Corporation $8.71 06/06/2024 Food and Beverage Undisputed 01/23/2026 1087179587 CMS
Novartis Pharmaceuticals Corporation $11.60 07/16/2024 Food and Beverage Undisputed 01/23/2026 1087179589 CMS
Novartis Pharmaceuticals Corporation $11.63 08/30/2024 Food and Beverage Undisputed 01/23/2026 1087179591 CMS
Novartis Pharmaceuticals Corporation $11.37 09/26/2024 Food and Beverage Undisputed 01/23/2026 1087179593 CMS
Novartis Pharmaceuticals Corporation $13.95 10/17/2024 Food and Beverage Undisputed 01/23/2026 1087179597 CMS
Novartis Pharmaceuticals Corporation $13.20 10/23/2024 Food and Beverage Undisputed 01/23/2026 1087179599 CMS
Novartis Pharmaceuticals Corporation $15.26 11/11/2024 Food and Beverage Undisputed 01/23/2026 1087179601 CMS
Novo Nordisk Inc $61.83 05/21/2024 Food and Beverage Undisputed 01/23/2026 1100607642 CMS
SCPHARMACEUTICALS INC. $15.09 01/12/2024 Food and Beverage Undisputed 01/23/2026 1132241131 CMS
SCPHARMACEUTICALS INC. $12.66 02/23/2024 Food and Beverage Undisputed 01/23/2026 1132254972 CMS
SCPHARMACEUTICALS INC. $20.43 10/02/2024 Food and Beverage Undisputed 01/23/2026 1132301814 CMS
SCPHARMACEUTICALS INC. $114.30 10/21/2024 Food and Beverage Undisputed 01/23/2026 1132305033 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.